📣 VC round data is live. Check it out!
- Public Comps
- Yifeng Pharmacy
Yifeng Pharmacy Valuation Multiples
Discover revenue and EBITDA valuation multiples for Yifeng Pharmacy and similar public comparables like CR Pharmaceutical, Jointown Pharmaceutical, Clicks Group, Nahdi Medical and more.
Yifeng Pharmacy Overview
About Yifeng Pharmacy
Yifeng Pharmacy Chain Co Ltd is mainly engaged in the chain retail business of medicines, health products, medical devices, and health-related daily convenience products. Its operating segments include the Retail segment and the Wholesale segment.
Founded
2008
HQ

Employees
40.0K
Website
Sectors
Financials (LTM)
EV
$3B
Valuation Multiples
Start free trialYifeng Pharmacy Financials
Yifeng Pharmacy reported last 12-month revenue of $4B and EBITDA of $464M.
In the same LTM period, Yifeng Pharmacy generated $1B in gross profit, $464M in EBITDA, and $260M in net income.
Revenue (LTM)
Yifeng Pharmacy P&L
In the most recent fiscal year, Yifeng Pharmacy reported revenue of $4B and EBITDA of $641M.
Yifeng Pharmacy is profitable as of last fiscal year, with gross margin of 39%, EBITDA margin of 18%, and net margin of 7%.
Financial data powered by Morningstar, Inc.
Yifeng Pharmacy Stock Performance
Yifeng Pharmacy has current market cap of $4B, and enterprise value of $3B.
Market Cap Evolution
Yifeng Pharmacy's stock price is $3.40.
Yifeng Pharmacy share price increased by 0.1% in the last 30 days, and decreased by 10.2% in the last year.
Yifeng Pharmacy has an EPS (earnings per share) of $0.20.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $3B | $4B | 0.0% | 0.1% | -4.7% | -10.2% | $0.20 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialYifeng Pharmacy Valuation Multiples
Yifeng Pharmacy trades at 0.9x EV/Revenue multiple, and 7.3x EV/EBITDA.
EV / Revenue (LTM)
Yifeng Pharmacy Financial Valuation Multiples
As of May 4, 2026, Yifeng Pharmacy has market cap of $4B and EV of $3B.
Yifeng Pharmacy has a P/E ratio of 15.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Yifeng Pharmacy Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Yifeng Pharmacy Margins & Growth Rates
Yifeng Pharmacy grew revenue by 9% but EBITDA decreased by 22% in the last fiscal year.
In the most recent fiscal year, Yifeng Pharmacy reported gross margin of 39%, EBITDA margin of 18%, and net margin of 7%.
Yifeng Pharmacy Margins
Yifeng Pharmacy Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Yifeng Pharmacy Operational KPIs
Yifeng Pharmacy's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
Yifeng Pharmacy's Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Yifeng Pharmacy's Rule of X is 35% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Yifeng Pharmacy Competitors
Yifeng Pharmacy competitors include CR Pharmaceutical, Jointown Pharmaceutical, Clicks Group, Nahdi Medical, Sugi Holdings, DaShenLin Pharmaceutical, COSMOS Pharmaceutical, Sundrug, Fragua and MatsukiyoCocokara.
Most Yifeng Pharmacy public comparables operate across Pharmacies.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.3x | 0.3x | 4.1x | 4.3x | |||
| 0.2x | 0.2x | 5.3x | 5.7x | |||
| 1.3x | 1.2x | 9.3x | 9.0x | |||
| 1.4x | 1.4x | 8.5x | 8.4x | |||
| 0.6x | 0.5x | 9.7x | 7.9x | |||
| 0.7x | 0.7x | 5.4x | 5.5x | |||
| 0.5x | 0.5x | 7.7x | 7.7x | |||
| 0.5x | 0.5x | 6.3x | 6.3x | |||
This data is available for Pro users. Sign up to see all Yifeng Pharmacy competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Yifeng Pharmacy
| When was Yifeng Pharmacy founded? | Yifeng Pharmacy was founded in 2008. |
| Where is Yifeng Pharmacy headquartered? | Yifeng Pharmacy is headquartered in China. |
| How many employees does Yifeng Pharmacy have? | As of today, Yifeng Pharmacy has over 40K employees. |
| Is Yifeng Pharmacy publicly listed? | Yes, Yifeng Pharmacy is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of Yifeng Pharmacy? | Yifeng Pharmacy trades under 603939 ticker. |
| When did Yifeng Pharmacy go public? | Yifeng Pharmacy went public in 2015. |
| Who are competitors of Yifeng Pharmacy? | Yifeng Pharmacy main competitors include CR Pharmaceutical, Jointown Pharmaceutical, Clicks Group, Nahdi Medical, Sugi Holdings, DaShenLin Pharmaceutical, COSMOS Pharmaceutical, Sundrug, Fragua, MatsukiyoCocokara. |
| What is the current market cap of Yifeng Pharmacy? | Yifeng Pharmacy's current market cap is $4B. |
| What is the current revenue of Yifeng Pharmacy? | Yifeng Pharmacy's last 12 months revenue is $4B. |
| What is the current revenue growth of Yifeng Pharmacy? | Yifeng Pharmacy revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Yifeng Pharmacy? | Current revenue multiple of Yifeng Pharmacy is 0.9x. |
| Is Yifeng Pharmacy profitable? | Yes, Yifeng Pharmacy is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Yifeng Pharmacy? | Yifeng Pharmacy's last 12 months EBITDA is $464M. |
| What is Yifeng Pharmacy's EBITDA margin? | Yifeng Pharmacy's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of Yifeng Pharmacy? | Current EBITDA multiple of Yifeng Pharmacy is 7.3x. |
| What is the current FCF of Yifeng Pharmacy? | Yifeng Pharmacy's last 12 months FCF is $379M. |
| What is Yifeng Pharmacy's FCF margin? | Yifeng Pharmacy's last 12 months FCF margin is 10%. |
| What is the current EV/FCF multiple of Yifeng Pharmacy? | Current FCF multiple of Yifeng Pharmacy is 8.9x. |
| How many companies Yifeng Pharmacy has acquired to date? | Yifeng Pharmacy hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Yifeng Pharmacy has invested to date? | Yifeng Pharmacy hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Yifeng Pharmacy
Lists including Yifeng Pharmacy
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.